NRX Pharmaceuticals, Inc. - Warrant - Nakit Akışı (NASDAQ:NRXPW)

Financials

İşletme faaliyetlerinden elde edilen nakit -598.62 K-37.7 M-39.76 M-21.66 M-10.64 M-14.11 M -14.93 M Yatırım faaliyetlerinden elde edilen nakit 26.18 M-7 000-10 K-3 0000-2.81 M — Finansman faaliyetlerinden elde edilen nakit -25.58 M63.46 M32.21 M6.2 M7.49 M23.28 M 19.11 M Serbest nakit akışı -598.62 K-37.71 M-39.77 M-21.66 M-10.64 M-14.11 M -14.93 M

NRXPW

Financials

Haberler

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty (NASDAQ:NRXP)

NRx Pharmaceuticals, Inc. (NRXP) Q4 2024 Earnings Call Transcript